1Abrams P, Cardozo L, Fall M, et al. The standardization of termi- nology of lower urinary tract function : report from the Standardization Subcommittee of the Ihternational Continence Society[J]. Neurourol Urodyn, 2002,21 : 167.
3Ikeda k, Kobayashi S, Suzuki M, et al. M3 receptor antagonism by the novel antimuscarinicagent solifenacin in the urinary bladder and salivary gland[ J]. Naunyn Schmiedebergs Arch PharmacoI, 2002,366:97 - 103.
4Kobayashi S, lkeda K, Miyata K. Comparison of in vitro selectivi- typrofiles of solifenacin succinate ( YM905 ) and current antimus- carinicdrugs in bladder and salivary glands: a Ca^2 + mobilization- study in monkey cells[ J]. Life Sc1,2004 ,74 :843 - 853.
5Ohtake A, Ukai M, Hatanaka T, et al. In vitro and in vivo tissue selectivity profile of solifenacinsuccinate ( YM905 ) for urinary bIadder over salivary gland inrats[ J]. Eur J PharmacoI, 2004, 492:243 - 250.
